Clinical Trials Browser

Phase 1/2 × Advanced Solid Tumor × olaparib × Clear all

NCT06525298 2024-09-19

EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor